906 followers
New article: Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status https://t.co/yEsuhtORwY #breastcancer #oncology https://t.co/IHO4Yt2bcX